Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 604-608

  Røder, Michael E ^b   Porte Jr , Daniel ^c   Schwartz, Robert S ^a   Kahn, Steven E ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; INSULIN; PROINSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; AGED, 80 AND OVER; ARGININE; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROINSULIN;

EID: 0031791047     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.2.604     Document Type: Article

References (39)

1. Gordon P, Hendricks CM, Roth J. 1974 Circulating proinsulin-like component in man. Increased proportion in hypoinsulinemic states. Diabetologia. 10:469-474.
2. Saad MF, Kahn SE, Nelson RG, et al. 1990 Disproportionately elevated pro-insulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 70:1247-1253.
3. Temple RC, Luzio SD, Schneider AE, et al. 1989 Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1:293-295.
4. DeFronzo RA, Bonadonna RC, Ferrannini E. 1992 Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:318-368.
5. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte Jr D. 1987 Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia. 30:698-702.
6. Kahn SE, Halban PA. 1995 Intact proinsulin and conversion intermediates recently released from B-cell granules in NIDDM. Diabetes. 44(Suppl 1):86A.
7. Roder ME, Vaag A, Hartling SG, et al. 1995 Proinsulin immunoreactivity in identical twins discordant for non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 80:2359-2363.
8. Porte Jr D. 1991 β-Cells in type 2 diabetes mellitus. Diabetes. 40:166-180.
9. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte Jr D. 1984 Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 74:1318-1328.
10. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY. 1495 Relationship of proinsulin and insulin with non-insulin dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity-Clinical Research Center study. J Clin Endocrinol Metab. 80:1399-1406.
11. Kahn SE, McCulloch DK, Schwartz MW, Palmer JP, Porte Jr D. 1992 Effect of insulin resistance, and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J Clin Endocrinol Metab. 74:192-197.
12. Røder ME, Knip M, Hartling SG, Karjalainen J, Åkerblom HK, Binder C. 1994 Disproportionately elevated proinsulin levels precede the onset of IDDM in siblings with low first-phase insulin responses. J Clin Endocrinol Metab. 79:1570-1575.
13. Kahn SE, Larson VG, Beard JC, et al. 1990 Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 258:E937-E943.
14. Ward WK, Paquette TL, Frank BH, Porte Jr D. 1986 A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide, and insulin. Clin Chem. 32:728-733.
15. Morgan DR, Lazarow A. 1963 Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes. 12:115-126.
16. Kahn SE, Prigeon RL, McCulloch DK, et al. 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42:1663-1672.
17. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y. 1988 Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 31:355-360.
18. Koivisto VA, Yki-Järvinen H, Hartling SG, Pelkonen R. 1986 The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma. J Clin Endocrinol Metab. 63:1117-1120.
19. Vestergaard H, Klein HH, Hansen T, et al. 1995 Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy. J Clin Invest. 95:1925-1932.
20. Porte Jr D, Kahn SE 1989 Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet β-cell dysfunction? Diabetes. 38:1333-1336.
21. Rhodes CJ, Alarcon C. 1994 What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes. 43:511-517.
22. Judzewitsch RG, Pfeiffer MA, Best JD, Beard JC, Halter JB, Porte Jr D. 1982 Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal, and stimulated insulin secretion by increasing islet sensitivity to glucose. J Clin Endocrinol Metab. 55:321-328.
23. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY. 1995 Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes. 44:173-179.
24. Berne C, Lithell H, Clark PMS, Hales CN. 1994 Split proinsulin is an early marker of non-insulin-dependent diabetes mellitus. Diabetologia. 37(Suppl 1):A57.
25. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Hales CN, Laakso M. 1995 Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia. 38:1176-1182.
26. Prigeon RL, Jacobson RK, Porte Jr D, Kahn SE. 1996 Effect of sulfonylurea withdrawal on proinsulin levels, B-cell function, and glucose disposal in subjects with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 81:3295-3298.
27. Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP. 1993 Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus. Diabetic Med. 10:293-298.
28. Brunzell JD, Robertson RP, Lerner RL, et al. 1976 Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 42:222-229.
29. Leahy JL, Bonner-Weir S, Weir GC. 1442 β-Cell dysfunction induced by chronic hyperglycemia. Diabetes Care. 15:442-455.
30. Clark A, Bown E, King T, Vanhegan RI, Turner RC. 1982 Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapy. Diabetes. 31:319-325.
31. Unger RH, Grundy S. 1985 Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia. 28:119-121.
32. Nauck MA, Siegel EG, Creutzfeldt W. 1991 Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Pancreas. 6:645-652.
33. Hartling SG, Røder ME, Dinesen B, Binder C. 1996 Proinsulin, C-peptide and insulin in normal subjects during eight hours hyperglycemic clamp. Eur J Endocrinol. 134:197-200.
34. Hartling SG, Lindgren F, Dahlqvist G, Persson B, Binder C. 1989 Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes. 38:1271-1274.
35. Heaton DA, Millward BA, Gray IP, et al. 1988 Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients. Diabetologia. 31:182-184.
36. Kahn SE, Horber FF, Prigeon RL, Haymond MW, Porte Jr D. 1993 Effect of glucocorticoid, and growth hormone treatment on proinsulin levels in humans. Diabetes. 42:1082-1085.
37. Roder ME, Dinesen B, Houssa P, Hartling SG, Sodoyez-Goffaux F, Binder C. 1995 Elevated intact proinsulin in NIDDM is not due to obesity. Diabetologia. 38(Suppl 1):A114.
38. Kahn SE, Beard JC, Schwartz MW, et al. 1989 Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes. 38:562-568.
39. Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte Jr D, Robertson RP. 1996 Hyperproinsulinemia is associated with increased β cell demand after hemipancreatectomy in humans. J Clin Invest. 47:455-460.